1. EXECUTIVE SUMMARY
2. MARKET SNAPSHOT
2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation
3. BUSINESS LANDSCAPE
3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter’s Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations
4. TECHNOLOGICAL OUTLOOK
5. PROTEIN EXPRESSION MARKET BY EXPRESSION SYSTEM
5.1. Introduction
5.2. Prokaryotic
5.3. Mammalian Cell
5.4. Insect Cell
5.5. Yeast
5.6. Others
6. PROTEIN EXPRESSION MARKET BY APPLICATION
6.1. Introduction
6.2. Therapeutic
6.3. Industrial
6.4. Research
7. PROTEIN EXPRESSION MARKET BY PRODUCT
7.1. Introduction
7.2. Reagents
7.3. Competent Cells
7.4. Expression Vectors
7.5. Services
7.6. Instruments
8. PROTEIN EXPRESSION MARKET BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. United Kingdom
8.4.4. Spain
8.4.5. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Indonesia
8.6.6. Thailand
8.6.7. Others
9. COMPETITIVE ENVIRONMENT AND ANALYSIS
9.1. Major Players and Strategy Analysis
9.2. Market Share Analysis
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Competitive Dashboard
10. COMPANY PROFILES
10.1. Agilent Technologies, Inc.
10.2. Bio-Rad Laboratories
10.3. Thermo Fisher Scientific, Inc.
10.4. Merck Millipore (Merck KGaA)
10.5. New England BioLabs, Inc.
10.6. Promega Corporation
10.7. QIAGEN
10.8. Takara Bio, Inc.
10.9. Oxford Expression Technologies
10.10. Lucigen Corporation
11. APPENDIX
11.1. Currency
11.2. Assumptions
11.3. Base and Forecast Years Timeline
11.4. Key benefits for the stakeholders
11.5. Research Methodology
11.6. Abbreviations
LIST OF FIGURES
LIST OF TABLES